Case Study:
Physician Segmentation and Marketing Actions
Physician Segmentation and Marketing Actions
In this case study the client discovered that the drug was not being used as it should as directed in the clinical guidelines for superior patient outcomes, in some physician segments. So they wanted to find out if there was a way to not only understand the segments but also to offer some sales and marketing levers that could influence the physicians to switch segments.
The Client Problem
• Oncology brand requiring maintenance therapy after induction
• Significant number of physicians not using maintenance preferring to treat at progression
• Oncologists tended to fall into 3 segments
• Insignificant switch between segments
The Solution
• Use big data and AI to:
◦ Understand which physicians fall into which segment
◦ Understand which influences lead individual physicians to make the maintenance choices they do, and therefore why they are in a specific segment
◦ Understand how to influence a dynamics between segments, in particular health care providers who are always using, selectively using and never using.
◦ Identify appropriate interventions that can be utilized by the sales and marketing teams to assist physicians in fully supporting the use of the maintenance treatment for patients where indicated.
◦ Map KOLs who believe in maintenance and utilize them and their network to influence non-believers
The Outcome
• 37% increase in physicians using maintenance treatment within 6 months
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
How to Overcome AI Resistance and Build an AI-Ready Workforce
In 2026, 81% of physicians reported using AI for work, more than double the 38% the American Medical Association recorded in 2023. Yet AI adoption
Nobody Has Banned AI in HTA Submissions. Everybody Has Made You Answerable for It.
What NICE, CDA-AMC and the new EU JCA principles now expect the moment AI touches your evidence, and the questions nobody has answered yet On
The Vendor You Evaluated Last Year Is Not the Product You Have Now Licensed
Somewhere in your organisation, there is a slide deck from twelve months ago. It has a scorecard on it. Green, amber, a few reds that